Type III hyperlipoproteinema with apolipoprotein E2/2 genotype in Japan
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Limited information is available concerning type III hyperlipoproteinemia (HLP) in the Asian population. Therefore, clinical and biochemical characteristics of type III HLP were examined in 16 Japanese patients. Mean plasma triglyceride (TG) and total cholesterol (chol) levels were 381 mg/dl and 253 mg/dl, respectively, and the mean very low density lipoprotein (VLDL)‐chol/plasma TG ratio was 0.27, which were lower than those reported in Western countries. Eighty percent of the patients had high plasma remnant‐like particles (RLP)‐chol levels above 50 mg/dl and a high RLP‐chol/plasma TG ratio above 0.1. Twelve patients (75.0%) were obese. Seven patients (43.8%) had type 2 diabetes mellitus and four patients (25.0%) had impaired glucose tolerance. Six patients (37.5%) had coronary heart disease (CHD), but none had peripheral vascular disease or xanthomas. TG‐rich lipoproteins from type III HLP patients with diabetes mellitus stimulated cholesteryl ester synthesis by human macrophages significantly (p < 0.001) more than those from type III HLP patients without diabetes mellitus. In conclusion, the Japanese type III HLP patients had lower plasma TG and total chol levels and a lower VLDL‐chol/plasma TG ratio, but CHD was more common. The patients were characterized by a high frequency of obesity and/or glucose intolerance. The TG‐rich lipoproteins from type III HLP patients with diabetes mellitus were more atherogenic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666 · cited 3×
“The diagnosis of type III HLP was made according to the following criteria: (1) increased plasma TG and/or total chol; (2) apo E2/2 genotype (phenotype); and (3) the presence of a broad b band on polyacrylamide gel electrophoresis (PAGE).”
BackgroundMethodThe biochemical, clinical, and genetic features of type III hyperlipoproteinemia.
MORGANROTH, J., LEVY, R. I., & FREDRICKSON, D. S. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-2-158 · Cited by 260
Diabetes and Cardiovascular Disease in a Prospective Population Survey in Japan: The Hisayama Study
Fujishima, M., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., & Yoshitake, T. (1996) · Diabetes · doi:10.2337/diab.45.3.s14 · Cited by 258 · cited 1×
“In the general Japanese population the frequency of type 2 diabetes was 13% for men and 9% for women, that of IGT was 20% for men and 19% for women, and that of obesity was below 30% according to the Hisayama study (27).”
BackgroundWhitman, S. C., Miller, D. B., Wolfe, B. M., Hegele, R. A., & Huff, M. W. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.9.1707 · Cited by 59 · cited 1×
“There is a possibility that remnant lipoproteins from diabetic type III HLP patients may undergo glycation and further oxidation (31,32) and therefore may be avidly taken up by macrophages, causing massive accumulation of chol in macrophages.”
BackgroundClinical features of type III hyperlipoproteinemia: analysis of 64 patients
Feussner, G., Wagner, A., Kohl, B., & Ziegler, R. (1993) · The Clinical Investigator · doi:10.1007/bf00186624 · Cited by 27
Cited by
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 302
Twickler, T. B., Dallinga-Thie, G. M., Cohn, J. S., & Chapman, M. J. (2004) · Circulation · doi:10.1161/01.cir.0000125278.58527.f3 · Cited by 201
Postprandial Hyperlipidemia and Remnant Lipoproteins
Masuda, D., & Yamashita, S. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv16003 · Cited by 145
Marais, A. D., Solomon, G. A. E., & Blom, D. J. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.870526 · Cited by 70
Metadata
- Authors
- Eto, M., Saito, M., Nakata, H., Iwashima, Y., Watanabe, K., Ikoda, A., & Kaku, K.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2002-06
- Volume
- 61
- Issue
- 6
- Pages
- 416-422
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W1501779041
- Cited by
- 16
- References
- 5
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Type III hyperlipoproteinema with apolipoprotein E2/2 genotype in Japan. https://app.cochat.ai/papers/10.1034/j.1399-0004.2002.610604.x
- The paper
- Eto, M., Saito, M., Nakata, H., Iwashima, Y., Watanabe, K., Ikoda, A., & Kaku, K. (2002). Type III hyperlipoproteinema with apolipoprotein E2/2 genotype in Japan. Clinical Genetics. https://doi.org/10.1034/j.1399-0004.2002.610604.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.